ADAPTIVE BIOTECHNOLOGIES Reports 20.7% Decrease in Revenue for Q3 FY2023
🌥️Earnings Overview On September 30, 2023, ADAPTIVE BIOTECHNOLOGIES ($NASDAQ:ADPT) reported their third quarter earnings results for FY2023, with total revenue [...]
Adaptive Biotechnologies Intrinsic Stock Value – Adaptive Biotechnologies Reports Strong Q3 Earnings
☀️Trending News This figure was driven mostly by increases in both their laboratory services and product revenue segments. It is [...]
Adaptive Biotechnologies Corp’s Upcoming Earnings Call: A Deep Dive Analysis
🌥️Introduction: Adaptive Biotechnologies Corp is set to release its second-quarter earnings results on August 2, 2023. As an equity analyst, [...]
Adaptive Biotechnologies Reports USD 48.9 Million Total Revenue and USD -47.8 Million Net Income for Q2 FY 2023
🌥️Earnings Overview For the second quarter of fiscal year 2023, ending June 30, 2023, ADAPTIVE BIOTECHNOLOGIES ($NASDAQ:ADPT) reported total revenue [...]
Jennison Associates LLC Decreases Adaptive Biotechnologies Co. Holdings by 21.9% in Q1
🌥️Trending News Adaptive Biotechnologies ($NASDAQ:ADPT) is a biotechnology company that specializes in developing tools and technology for the advancement of [...]
Adaptive Biotechnologies Intrinsic Value Calculator – Adaptive Biotechnologies Reports Strong Financial Performance, Beating Estimates by $0.78 EPS and $0.69M Revenue.
Trending News ☀️ The company reported GAAP earnings per share of $0.40, surpassing expectations, and a revenue of $37.6M that [...]
Adaptive Biotechnologies Intrinsic Value – Cwm LLC Decreases Holdings in Adaptive Biotechnologies Corp. as Analysts Offer Mixed Opinions
Trending News 🌥️ Adaptive Biotechnologies ($NASDAQ:ADPT) Corp. is a leading biotechnology company focused on transforming the understanding and treatment of [...]
Clarius Group LLC Reduces Stake in Adaptive Biotechnologies Co. by 22.5% in Fourth Quarter
Trending News 🌥️ Adaptive Biotechnologies ($NASDAQ:ADPT) is a biotechnology company that focuses on creating transformative solutions to revolutionize the understanding, [...]
Adaptive Biotechnologies Stock Fair Value – Putnam Investments LLC Reduces Investment in Adaptive Biotechnologies Co. in 2023.
Trending News 🌥️ Adaptive Biotechnologies ($NASDAQ:ADPT) Co. has experienced a substantial decrease in its stake held by Putnam Investments LLC [...]
Adaptive Biotechnologies Reports Q4 2023 GAAP EPS of -$0. 28, Beating Analyst Estimates by $0. 06.
Trending News 🌧️ Adaptive Biotechnologies ($NASDAQ:ADPT) reported a Q4 GAAP EPS of -$0. Adaptive Biotechnologies is a biotech company that [...]
